Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

DelveInsight’s, “Colorectal Cancer Pipeline Insight 2025” report provides comprehensive insights about 195+ companies and ...

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

More than half of patients with ischemic stroke experience futile reperfusion, increasing the risk of death and disabilities despite a successful recanalization. The reason behind this is debated, and ...

Diacylglycerol kinases (DGKs) are a family of enzymes that regulate the ... Both DAG and PA are important second messengers cascading T cell receptor (TCR) signal by recruiting multiple effector ...

The authors provide convincing evidence indicating that two receptor tyrosine kinases (RTKs), CAD96CA and FGFR1, modulate the genomic effects of JH by phosphorylating the intracellular receptors in ...

In particular, the presence of receptor tyrosine kinases (RTKs) that phosphorylate Met/Tai in response to JH and thus indirectly affect the canonical JH signaling pathway has been strongly suggested.

Eph receptors are the largest subfamily of receptor tyrosine kinases (RTK). Overexpression of EphA2 is a common signature for many types of human solid cancer including glioblastoma, melanoma and ...

Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia ...